These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22381246)

  • 1. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
    Mester JL; Zhou M; Prescott N; Eng C
    Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome : Clinicopathologic Study of 12 Renal Cell Carcinomas From 9 Patients and Association With Intrarenal "Lipomas".
    Kozman D; Kao CS; Nguyen JK; Smith SC; Kehr EL; Tretiakova M; Przybycin CG; Williamson SR; Argani P; Eng C; Campbell SC; McKenney JK; Alaghehbandan R
    Am J Surg Pathol; 2023 Sep; 47(9):1001-1010. PubMed ID: 37357918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female.
    Ramkumar RR; Murthy PB; Nguyen JK; McKenney J; Eng C; Campbell SC
    Urology; 2021 Feb; 148():113-117. PubMed ID: 33227300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer.
    Shuch B; Ricketts CJ; Vocke CD; Komiya T; Middelton LA; Kauffman EC; Merino MJ; Metwalli AR; Dennis P; Linehan WM
    J Urol; 2013 Dec; 190(6):1990-8. PubMed ID: 23764071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime cancer risks in individuals with germline PTEN mutations.
    Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
    Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.
    Bennett KL; Campbell R; Ganapathi S; Zhou M; Rini B; Ganapathi R; Neumann HP; Eng C
    Genes Chromosomes Cancer; 2011 Aug; 50(8):654-61. PubMed ID: 21584899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
    Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
    Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
    Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
    Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
    Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.
    Stanich PP; Pilarski R; Rock J; Frankel WL; El-Dika S; Meyer MM
    World J Gastroenterol; 2014 Feb; 20(7):1833-8. PubMed ID: 24587660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.
    Roldan-Romero JM; Santos M; Lanillos J; Caleiras E; Anguera G; Maroto P; García-Donas J; de Velasco G; Martinez-Montes ÁM; Calsina B; Monteagudo M; Letón R; Leandro-García LJ; Montero-Conde C; Cascón A; Robledo M; Rodriguez-Antona C
    Mod Pathol; 2020 Dec; 33(12):2580-2590. PubMed ID: 32616874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
    Hendricks LAJ; Hoogerbrugge N; Mensenkamp AR; Brunet J; Lleuger-Pujol R; Høberg-Vetti H; Tveit Haavind M; Innella G; Turchetti D; Aretz S; Spier I; Tischkowitz M; Jahn A; Links TP; Olderode-Berends MJW; Blatnik A; Leter EM; Evans DG; Woodward ER; Steinke-Lange V; Anastasiadou VC; Colas C; Villy MC; Benusiglio PR; Gerasimenko A; Barili V; Branchaud M; Houdayer C; Tesi B; Yazicioglu MO; van der Post RS; Schuurs-Hoeijmakers JHM; ; Vos JR
    J Natl Cancer Inst; 2023 Jan; 115(1):93-103. PubMed ID: 36171661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
    Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
    J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
    Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
    J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
    Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
    Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain morphological analysis in PTEN hamartoma tumor syndrome.
    Shiohama T; Levman J; Vasung L; Takahashi E
    Am J Med Genet A; 2020 May; 182(5):1117-1129. PubMed ID: 32162846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.